Part of Amgen, Inc., Onyx Therapeutics, Inc. is a company headquartered in the United States that discovers, develops and commercializes novel therapeutics.

CV Therapeutics, Inc. operates as a research-based biopharmaceutical company. The Company researches and manufactures drugs for the treatment of cardiovascular disease and more specifically angina pectoris. CV Therapeutics serves the healthcare industry in the United States. CV Therapeutics developed Ranexa, a drug to treat chronic angina; and Lexiscan, an injection used as a stress agent in cardiovascular procedures. The company was acquired by Gilead Sciences, the maker of H.I.V. drugs Truvada, Viread, and Atriplia, for about $1.4 billion.

Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA

The Max Planck Society for the Advancement of Science (German: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V.; abbreviated MPG) is a non-governmental and non-profit association of Research Institutes publicly funded by the federal and the state governments of Germany. Additionally, the Max Planck Society and its Institutes receive third party funding from public and private contributions and from the European Union. The world leading organization is named in honor of its former president, theoretical physicist Max Planck. The 86 Institutes and Research Facilities of the Max Planck Society (as of 2020) conduct basic research in the natural sciences, life sciences, social sciences, and the arts and humanities. They have a total staff of approximately 24,000 permanent employees, including 15,000 scientists, and around 5,000 non-tenured scientists and guests. As of December 31, 2018, the proportion of female employees was 44.4 percent. The Max Planck Society (with its 86 Max Planck Institutes) has a world-leading reputation as a science and technology research organization, with more than 33 Nobel Prizes awarded to its scientists, and is widely regarded as one of the foremost basic research organizations in the world.

Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is an American company located in Cambridge, MA, that develops anti-cancer treatments. The firm was founded by Tom Maniatis. On July 20, 1999 LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. since December 1999, acquired ProScript, Inc. for $3.35 million.

Nanjing Lingrui Pharmaceutical Technology Co., Ltd., established on 2018-06-06, Business scope includes medical technology consulting,technology transfer,technology development,Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Wuhan Baiyao Lianke Technology Co., Ltd., established on 2017-02-23, Business scope includes technical development of biological products and drugs,technology transfer;patent agency(Operate within the approved period with the license);Business Consulting(Does not include business surveys);Import and export,Technology Import and Export,Agent import and export(Does not contain goods or technologies that are prohibited or restricted from import and export by the state).(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Bayer CropScience NV, part of Bayer AG, is a Belgian company located in Diegem. The firm wholesales fertilizers and other agrochemical products. It was founded in 1972. Sylvain Moissionnier has been the CEO since 2020.

ViroLogik is a biopharmaceutical company which is focusing on innovative drugs for treatment of viral diseases. The focus is on Hepatitis C (HCV). Second indication is HIV- (Human Immunodeficiency Virus, AIDS) infections. ViroLogik is following a novel strategy to prevent formation of drug resistance. ViroLogik has clinical proof of concept with a proteasome inhibitor in Hepatitis C patients refractory to standard therapy. Formal preclinical development of ViroLogik’s own development candidate VL-01 is progressing. ViroLogik is following a novel strategy to prevent formation of drug resistance. The approach aims at inhibition of the highly conserved host cell proteasome which is essential for viral replication. This is in contrast to many current drugs which target fast mutating viral proteins and, hence, are prone to induction of drug resistance.

Shenzhen Jikang Pharmaceutical Technology Co., Ltd., established on 2021-02-03, Business scope includes general business items:Biotechnology,R&D of pharmaceuticals and medical devices,technical consulting,technology transfer;Health and wellness management consulting(Except for medical treatment activities subject to approval);Provide logistics management consulting for pharmaceutical companies;Conference and exhibition planning;Domestic Trade,Operating import and export business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments),The licensing program is:medicine,Sales of food and medical equipment

Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education. - Identify and assess research projects with commercial potential. - Protect the intellectual property of the Institute and its scientists. - Create business relationships and license the Institute’s inventions and technologies to the industry. - Channel funding from industry to research projects. For further information please contact Tamir Huberman, CIO and Head of Marketing

Amgen Biomedical (Shanghai) Co., Ltd., established on 2018-03-21, Business scope includes international trade,Re-export trade,Trade between enterprises in the region and trade agency in the region,Western medicine,Wholesale of traditional Chinese medicine,commission agent(except auction),Import and export and other supporting services,Warehousing and distribution business in the region(In addition to dangerous goods),Simple commercial processing in the region,Trade Advisory Services,engaged in biotechnology(Development and application of human stem cells and gene diagnosis and treatment technology)and medical technology(Development and application of human stem cells and gene diagnosis and treatment technology)Technology development in the field of expertise,technical consulting,Technical Services,technology transfer,Non-residential real estate leases,Entrusted by the parent company and its authorized management of domestic enterprises and affiliated enterprises in China,Provide them with daily operation and management decisions,Merchandising,Marketing Services,Supply Chain and Distributor Management. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Bayer CropScience is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. People at Bayer CropScience are committed to help tackle challenges with their expertise in high value seeds, innovative chemical and biological crop protection solutions, and services for modern, sustainable agriculture. Their daily work – in the lab and on the ground – focuses on how they can help farmers across the globe overcome their challenges. With the “head of a scientist” and the “heart of a farmer” they bring innovative and inspiring solutions directly to their customers, along with reliable services and advice. And thus support food production where it begins: on the field.

Onyx Pharmaceuticals Inc. is a biopharmaceutical company headquartered in South San Francisco, California. The company develops and markets medicines for the treatment of cancer. Onyx was founded in 1992 by Kevin J. Kinsella and Frank McCormick Ph.D., FRS. In 2009, the company acquired Proteolix, Inc., a private biotechnology company. In January 2012, the company was named "the top biotechnology takeover target in 2012" through an industry survey. Onyx CEO Tony Coles had said that Onyx liked its prospects as an independent company and was focused on bringing new therapies to patients. However, at the end of August 2013, Amgen announced it was acquiring Onyx in an agreed $10.4 billion deal.

The Dutch Cancer Society (DCS; in Dutch: 'KWF Kankerbestrijding' ) is a Dutch Society committed to fight cancer by scientific research, education, patient support and fundraising in cooperation with volunteers, donors, patients, doctors and researchers. By this commitment, DCS targets less cancer, more cures and a higher quality of life for cancer patients. Its motto is, 'Everyone Deserves a Tomorrow' .

University Health Network (UHN) is a healthcare and medical research organization in Toronto, Ontario, Canada. It is the largest such research organization in Canada and North America, ranking first in Canada for total research funding. It was named Canada's top research hospital by Research Infosource in 2015, 2016 and 2017. It was created in 1986 by the Government of Ontario through the merger of four major hospitals: Toronto General Hospital, Toronto Western Hospital, with the Princess Margaret Cancer Centre, and the Toronto Rehabilitation Institute merged in with The Toronto Hospital in 1999 and the name changed to the University Health Network. All four hospitals are affiliated with the Faculty of Medicine at the University of Toronto and serve as teaching hospitals for resident physicians, nurses, and other healthcare professions. UHN also operates The Michener Institute, an applied health sciences college that opened in 1958.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Trustees of Dartmouth College, part of Dartmouth College, is a company headquartered in Hanover, NH. The firm operates higher education institutes. It was founded in 1769.